Can an arthritis drug shrink hidden HIV? small study begins to find out
NCT ID NCT07028385
First seen Dec 16, 2025 · Last updated May 15, 2026 · Updated 20 times
Summary
This study tests whether baricitinib, a drug used for arthritis, is safe and can reduce the hidden HIV reservoir in 30 people whose HIV is already well-controlled by standard medication. Participants take either baricitinib or a placebo daily for 12 weeks while continuing their regular HIV drugs. The goal is to learn about safety and how the drug affects immune cells, not to cure HIV.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fundació Lluita contra les Infeccions - Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, 08916, Spain
Conditions
Explore the condition pages connected to this study.